Prasugrel plus bivalirudin vs. clopidogrel plus heparin in patients with ST-segment elevation myocardial infarction

Schulz S, Richardt G, Laugwitz KL, Morath T, Neudecker J, Hoppmann P, Mehran R, Gershlick AH, Toelg R, Fiedler KA, Abdel-Wahab M, Kufner S, Schneider S, Schunkert H, Ibrahim T, Mehilli J, Kastrati A (2014)


Publication Type: Journal article

Publication year: 2014

Journal

Book Volume: 35

Pages Range: 2285-2294

Journal Issue: 34

DOI: 10.1093/eurheartj/ehu182

Abstract

Aims Whether prasugrel plus bivalirudin is a superior strategy to unfractionated heparin plus clopidogrel in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI) has never been assessed in specifically designed randomized trials.

Involved external institutions

How to cite

APA:

Schulz, S., Richardt, G., Laugwitz, K.-L., Morath, T., Neudecker, J., Hoppmann, P.,... Kastrati, A. (2014). Prasugrel plus bivalirudin vs. clopidogrel plus heparin in patients with ST-segment elevation myocardial infarction. European Heart Journal, 35(34), 2285-2294. https://dx.doi.org/10.1093/eurheartj/ehu182

MLA:

Schulz, Stefanie, et al. "Prasugrel plus bivalirudin vs. clopidogrel plus heparin in patients with ST-segment elevation myocardial infarction." European Heart Journal 35.34 (2014): 2285-2294.

BibTeX: Download